These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they have drawbacks.

Yet most insurance plans won’t cover the drugs for weight loss. A 2022 FDA-declared shortage led to the rise of compounded GLP-1s — pharmacy-made versions not FDA-approved but allowed temporarily.